Unity upgrade, UiPath earnings, Regeneron drug trial results
Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Unity Software's (U) upgrade to Buy from Jefferies analysts, UiPath (PATH) beating its earnings estimates, and Regeneron Pharmaceuticals (REGN) taking a stock hit on its mixed drug trial results for an experimental treatment to a condition referred to as smoker's lung. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.